The significant miss in both EPS and sales compared to analyst estimates, along with a substantial decrease from the previous year's figures, suggests a negative short-term impact on CYRX's stock price. The earnings miss, especially being greater than 20%, and the sales miss indicate underlying challenges that could concern investors, potentially leading to decreased investor confidence and a drop in stock price.